Quest Diagnostics DGX
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Quest Diagnostics (DGX) Business Model and Operations Summary
Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Key Insights
Quest Diagnostics (DGX) Core Market Data and Business Metrics
Latest Closing Price
$169.28Market Cap
$18.79 BillionPrice-Earnings Ratio
22.01Total Outstanding Shares
110.98 Million SharesTotal Employees
56,000Dividend
$0.80 Per Share QuarterlyIPO Date
December 17, 1996SIC Description
Services-medical LaboratoriesPrimary Exchange
New York Stock ExchangeHeadquarters
500 Plaza Drive, Secaucus, NJ, 07094
Historical Stock Splits
If you bought 1 share of DGX before June 21, 2005, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| June 21, 2005 | 2-for-1 |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-2.55 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-2.55 Billion |
| Exchange Gains/Losses | $-7 Million |
| Net Cash Flow From Operating Activities, Continuing | $1.33 Billion |
| Net Cash Flow, Continuing | $-130 Million |
| Net Cash Flow From Operating Activities | $1.33 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Operating Expenses | $1.90 Billion |
| Income/Loss From Continuing Operations After Tax | $902 Million |
| Selling, General, and Administrative Expenses | $1.77 Billion |
| Other Operating Expenses | $128 Million |
| Interest And Dividend Income, Operating | $25 Million |
| Cost Of Revenue | $6.63 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $847 Million |
| Other Comprehensive Income/Loss | $-74 Million |
| Comprehensive Income/Loss Attributable To Parent | $797 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $50 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Equity Attributable To Parent | $6.78 Billion |
| Liabilities And Equity | $16.15 Billion |
| Intangible Assets | $1.76 Billion |
| Inventory | $188 Million |
| Noncurrent Liabilities | $7.09 Billion |
| Other Non-current Liabilities | $871 Million |
Historical Dividends
Current dividend: $0.80 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 30, 2025 | Apr 21, 2025 | Apr 7, 2025 | $0.8 | Quarterly |
| Nov 12, 2024 | Jan 29, 2025 | Jan 14, 2025 | $0.75 | Quarterly |
| Aug 14, 2024 | Oct 21, 2024 | Oct 4, 2024 | $0.75 | Quarterly |
| May 15, 2024 | Jul 22, 2024 | Jul 8, 2024 | $0.75 | Quarterly |
| Feb 1, 2024 | Apr 22, 2024 | Apr 8, 2024 | $0.75 | Quarterly |
| Nov 13, 2023 | Jan 31, 2024 | Jan 17, 2024 | $0.71 | Quarterly |